Stocks and Investing
Stocks and Investing
Fri, August 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kristen Kluska Maintained (ADMA) at Buy with Increased Target to $20 on, Aug 9th, 2024
Kristen Kluska of Cantor Fitzgerald, Maintained "ADMA Biologics, Inc." (ADMA) at Buy with Increased Target from $15 to $20 on, Aug 9th, 2024.
Kristen has made no other calls on ADMA in the last 4 months.
There are 3 other peers that have a rating on ADMA. Out of the 3 peers that are also analyzing ADMA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Kristen
- Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $14 on, Thursday, June 20th, 2024
- Elliot Wilbur of "Raymond James" Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
Contributing Sources